Primary resistance to abiraterone acetate (AA) after docetaxel treatment in metastatic castration-resistant prostate cancer (mCRPC): A multicenter retrospective analysis.

被引：0
|
作者：
Maruzzo, Marco
Basso, Umberto
Diminutto, Alberto
De Giorgi, Ugo
Fratino, Lucia
Lo Re, Giovanni
D'Angelo, Alessandro
Donini, Maddalena
Verderame, Francesco
Ratta, Raffaele
Procopio, Giuseppe
Campadelli, Enrico
Massari, Francesco
Gasparro, Donatello
Macrini, Sveva
Messina, Caterina
Giordano, Monica
Maines, Francesca
Zagonel, Vittorina
Caffo, Orazio
机构：
[1] IRCCS, IOV, Med Oncol 1, Padua, Italy
[2] IRCCS, Ist Oncol Veneto, Padua, Italy
[3] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy
[4] Natl Canc Ctr CRO, Aviano, Italy
[5] Santa Maria Degli Angeli Gen Hosp, Pordenone, Italy
[6] Civil Hosp, Taormina, Italy
[7] Ist Ospitalieri Cremona, Cremona, Italy
[8] Cervello Hosp, Palermo, Italy
[9] Unicampus Univ, Rome, Italy
[10] Ist Nazl Tumori, Fdn IRCCS, Oncol Unit 1, I-20133 Milan, Italy
[11] Civil Hosp, Lugo Di Romagna, Italy
[12] Univ Verona, Med Oncol, Azienda Osped Univ Integrata, I-37100 Verona, Italy
[13] Univ Hosp Parma, Parma, Italy
[14] Univ Hosp, Udine, Italy
[15] Pope John Paul XXIII Hosp, Med Oncol Unit, Bergamo, Italy
[16] Santa Anna Hosp, Como, Italy
[17] Santa Chiara Hosp, Trento, Italy
[18] IRCCS, Ist Oncol Veneto, Oncol Med 1, Padua, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.206
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
206
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and clinical outcomes of abiraterone acetate (aa) after docetaxel (doc) in octogenarians with metastatic castration-resistant prostate cancer (mcrpc)
    Caffo, O.
    Maines, F.
    De Giorgi, U.
    Fratino, L.
    Lo Re, G.
    Zagonel, V.
    D'Angelo, A.
    Donini, M.
    Verderame, F.
    Ratta, R.
    Procopio, G.
    Campadelli, E.
    Massari, F.
    Gasparro, D.
    Ermacora, P.
    Messina, C.
    Giordano, M.
    Alesini, D.
    Conteduca, V.
    Veccia, A.
    Galligioni, E.
    ANNALS OF ONCOLOGY, 2015, 26 : 61 - 61
  • [2] Sequencing of cabazitaxel and abiraterone acetate following docetaxel in metastatic castration-resistant prostate cancer (mCRPC)
    Schnadig, Ian D.
    Bhor, Menaka
    Vogelzang, Nicholas J.
    Hennessy, Daniel
    Nicacio, Leonardo V.
    Berry, William R.
    Hutson, Thomas E.
    Fleming, Mark T.
    Cowey, C. Lance
    Saravanan, Shanmugapriya
    Dhanda, Rahul
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [3] A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer
    Ueda, Yujiro
    Matsubara, Nobuaki
    Takizawa, Itsuhiro
    Nishiyama, Tsutomu
    Tabata, Ken-ichi
    Satoh, Takefumi
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    Kawahara, Takashi
    Uemura, Hiroji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (08) : 774 - 779
  • [4] Predictors of outcome to post-docetaxel abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC) patients (p)
    Ochoa de Olza, M.
    Font, A.
    Sala, N.
    Beltran, M.
    Barretina, P.
    Etxaniz, O.
    Indacoechea, A.
    Hernandez, A.
    Navarro, V.
    Germa, J. R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S701 - S701
  • [5] Assessment of prognostic factors in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (AA) after docetaxel (DOC).
    Cavaliere, Carla
    Caffo, Orazio
    Ortega, Cinzia
    D'aniello, Carmine
    Di Napoli, Marilena
    Cecere, Sabrina Chiara
    Della Pepa, Chiara
    Crispo, Anna
    Maines, Francesca
    Ruatta, Fiorella
    Iovane, Gelsomina
    Montella, Maurizio
    Pignata, Sandro
    Facchini, Gaetano
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] A real-life multicenter, retrospective analysis of Abiraterone Acetate (AA) in 340 metastatic castration-resistant prostate cancer (mCRPC) patients after chemotherapy, updated results
    Fabbri, M. A.
    Sternberg, C. N.
    Cortesi, E.
    Santini, D.
    Procopio, G.
    Paolo, M.
    Gamucci, T.
    Carlini, P.
    Roselli, M.
    Longo, F.
    Schinzari, G.
    De Tursi, M.
    Lanzetta, G.
    Pellegrino, A.
    Milano, A.
    Sperduti, I.
    Mancini, M. L.
    Primi, F.
    Ruggeri, E. M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [7] Abiraterone acetate (AA) with or without cabazitaxel (CBZ) in treatment of chemotherapy naive metastatic castration-resistant prostate cancer (mCRPC)
    Slovin, Susan F.
    Knudsen, Karen E.
    Halabi, Susan
    Fleming, Mark T.
    Molina, Ana M.
    Wolf, Steven Paul
    de Leeuw, Renee
    Fernandez, Celina
    Kang, Praneet
    Southwell, Traci
    Jones, Carol L.
    Fernandez, Escarleth
    Kelly, William Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [8] Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC).
    Maughan, Benjamin Louis
    Suzman, Daniel L.
    Nadal, Rosa
    Bassi, Sunakshi
    Schweizer, Michael Thomas
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [9] Evaluating the safety of abiraterone acetate (AA) and docetaxel (D) administered in combination in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Tagawa, Scott T.
    Nanus, David M.
    Posadas, Edwin M.
    Petrylak, Daniel Peter
    Bruce, Justine Yang
    Lim, Emerson A.
    Peng, Weimin
    Maul, Raymond Scott
    Gonzalez, Martha
    Tran, Namphuong
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [10] Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology
    Demirci, Umut
    Oflazoglu, Utku
    Kodaz, Hilmi
    Ciltas, Aydin
    Kefeli, Umut
    Akyol, Murat
    Ozturk, Banu
    Geredell, Caglayan
    Seker, Mehmet Metin
    Clhan, Saner
    Tastekin, Dldem
    Sevinc, Alper
    Akinci, Muhammad Bulent
    Uysal, Mukremin
    Taskoylu, Burcu Yapar
    Duran, Ayse Ocak
    Yazici, Omer Komi
    Karaoglu, Aziz
    Benekli, Mustafa
    Buyukberber, Suleyman
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345